Pfizer RSV Vaccine Abrysvo gets USFDA ok for high-risk adults aged 18-59 MD Bureau23 Oct 2024 2:37 PM ISTThe approval for the vaccine, Abrysvo, in adults aged 18 to 59 was based on the results from a late stage trial in which two doses of the vaccine were...
Medical Bulletin 21/ October/ 2024 Dr. Bhumika Maikhuri21 Oct 2024 3:00 PM ISTHere are the top medical news for the day:Innovative Surgical Techniques Used in World’s First Combined Face and Whole-Eye TransplantationAn...
Approximately 80 Percent Protection May be Provided by RSV Vaccine Against Severe Disease and Death: Study Suggests Dr. Bhumika Maikhuri21 Oct 2024 8:15 AM ISTA multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the respiratory syncytial virus...
GSK alleges patent infringement by Moderna in development of COVID19, RSV vaccines, files lawsuit MD Bureau16 Oct 2024 3:51 PM ISTLondon: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating...
Pfizer wins bid to invalidate 2 GSK patents relating to RSV vaccine Ruchika Sharma9 Oct 2024 2:33 PM ISTLondon: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held by GlaxoSmithKline (GSK)...
Moderna forecasts lower sales next year, shares near four-year low MD Bureau Team14 Sept 2024 11:34 AM ISTLondon: Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key products and predicted...
New RSV vaccine can result in individual and societal cost savings, benefits for elderly: Study Dr. Kamal Kant Kohli6 Sept 2024 8:30 PM ISTVaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of...
New JAMA study backs RSV vaccine safety during pregnancy Dr. Kamal Kant Kohli10 July 2024 4:00 AM ISTVaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk...
USFDA approves expanded age indication for GSK RSV vaccine Arexvy for adults aged 50-59 at increased risk Ruchika Sharma9 Jun 2024 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine,...
Moderna gets USFDA nod for mRNA RSV vaccine Ruchika Sharma2 Jun 2024 1:30 PM ISTCambridge: Moderna, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory...
Modify CT Protocol: CDSCO Panel Tells GSK on Respiratory Syncytial Virus(RSV) Vaccine Dr. Divya Colin24 March 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial protocol presented by the drug major GSK for the Respiratory Syncytial Virus (RSV) vaccine...
RSV vaccine Abrysvo is protective through a second year: Pfizer Ruchika Sharma3 March 2024 12:00 PM ISTNew York: Pfizer has said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the...
